Hansoh Pharmaceutical Group Company Limited (3692)

Name: Hansoh Pharmaceutical Group Company Limited (3692) — storico dei bilanci
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Storico di ricavi, utili e flussi di cassa dai bilanci ufficiali.

Healthcare · Wall Street (USA) · Ultimo aggiornamento: 2026-09-30

Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People's Republic of China. The company provides products for therapeutic areas, including anti-infection, central nervous system, oncology, and metabolic and other diseases, as well as autoimmune diseases.

Dati chiave

Capitalizzazione di mercato: HK$214 billion
Ricavi (esercizio chiuso a 2025-12-31): CNY 15.0B
Utile netto: CNY 5.6B
Margine lordo: 90.0%
Margine netto: 37.0%

Vedi grafici interattivi e bilanci completi → Modello di valutazione (DCF) →

Conto economico annuale

Conto economico	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Entrate totali	CNY 15.0B	CNY 12.3B	CNY 10.1B	CNY 9.4B
Utile lordo	CNY 13.5B	CNY 11.2B	CNY 9.1B	CNY 8.5B
Risultato Operativo (EBIT)	CNY 5.5B	CNY 4.0B	CNY 2.8B	CNY 2.8B
Reddito netto	CNY 5.6B	CNY 4.4B	CNY 3.3B	CNY 2.6B

Fonte: bilanci pubblici della società (SEC). Verificare su SEC EDGAR prima di fare affidamento su qualsiasi cifra.

Stati patrimoniali, flussi di cassa, dati trimestrali e indici completi nel visualizzatore interattivo di 3692. /companies/us/3692

Aziende simili

Le informazioni di questo sito sono solo a scopo educativo e informativo; non costituiscono consulenza finanziaria. Non vengono pubblicati prezzi obiettivo né raccomandazioni.

English version →Tutte le azioni

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.